Zhang B, Li Y, Ma T
Liaoning Provincial Tumor Hospital, Shenyang 110042, China.
Zhonghua Zhong Liu Za Zhi. 2000 Jul;22(4):298-300.
To evaluate the practical significance of microvessel count (MVC), c-erbB-2, CD44, cathepsin D and nm23 expression, and clinico-pathological parameters in the prognosis of node-negative breast cancer.
Sixty two patients with node-negative invasive breast cancer were treated by surgery alone, and followed-up for at least 10 years. Microvessel count (MVC), C-erbB-2, CD44, Cathepsin D and nm23 expression were studied by immunohistochemical technique. With other clinico-pathological parameters, they were evaluated prognostically.
Univariate analysis showed that the prognostic factors influencing 10-year overall survival rate were MVC, C-erbB-2, stromal cell cath-D and CD44 expression. Multivariate analysis demonstrated that MVC was the sole independent prognostic factor determining 10-year survival.
Although MVC, c-erbB-2, stromal cell cath-D and CD44 expression are all of prognostic significance, MVC is most meaningful in evaluating prognosis of node-negative breast cancer patients.
评估微血管计数(MVC)、c-erbB-2、CD44、组织蛋白酶D和nm23表达以及临床病理参数在腋窝淋巴结阴性乳腺癌预后中的实际意义。
62例腋窝淋巴结阴性浸润性乳腺癌患者仅接受手术治疗,并随访至少10年。采用免疫组织化学技术研究微血管计数(MVC)、C-erbB-2、CD44、组织蛋白酶D和nm23表达。结合其他临床病理参数,对其预后进行评估。
单因素分析显示,影响10年总生存率的预后因素为MVC、C-erbB-2、基质细胞组织蛋白酶D和CD44表达。多因素分析表明,MVC是决定10年生存率的唯一独立预后因素。
虽然MVC、c-erbB-2、基质细胞组织蛋白酶D和CD44表达均具有预后意义,但MVC在评估腋窝淋巴结阴性乳腺癌患者预后方面最具意义。